🔴 Chimeric Therapeutics is trading 16.67% down today with no clear company-specific catalyst

Chimeric Therapeutics is trading 16.67% down at A$0.01, with no clear company-specific catalyst identified for the September 23, 2026 decline.

• Recent disclosures included an application to quote new shares.
• The biotech sector fell 2.04%, while broader equity markets weakened.
• The broader risk-off environment likely added pressure, but available evidence does not establish a direct causal link to Chimeric Therapeutics.